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Background: Salvage surgeries are challenging procedures, with an associated poor prognosis. Man-
agement of the N0 neck in those situations remains controversial. We aim to compare oncologic out-Pharyngo-laryngeal squamous cell
carcinoma
Elective neck dissection
Occult lymph node metastasis
Organ preservation
Salvage surgeryIntroduction
cades, of radiotherapy (RT) protocols for th
31059, Toulouse, France.
E-mail address: vergez.s@chu-toulouse.fr (S. Verge
https://doi.org/10.1016/j.ejso.2020.01.011 comes regarding neck management after surgery for N0 pharyngo-laryngeal carcinoma occurring after
loco-regional radiotherapy.
Methods: We conducted a multicentric retrospective study, including all patients undergoing surgery for
persistent, recurrent or new primary N0 carcinoma of the oropharynx, hypopharynx or larynx between
2005 and 2015, following loco-regional radiotherapy.
Results: A total of 239 patients were included, concerning respectively 44%, 34% and 22% oropharyngeal,
laryngeal and hypopharyngeal tumors operated. A neck dissection was performed in 143 patients (60%),
with an occult nodal metastasis rate of 9%. This rate was higher for hypopharyngeal carcinomas (18%,
p ¼ 0.16) and tumors with initial nodal involvement (16%, p ¼ 0.05). With a median follow-up of 60
months, the median overall survival (OS) and progression-free survival rates (PFS) were 34 months and
25 months. We identified negative margin excision status, age at the time of surgery (under 60) and
delay between RT and surgery over 2 years as the only variables associated with better OS (p < 0.0001
and p ¼ 0.004) and PFS (p < 0.0001 and p ¼ 0.010) in multivariable analysis, with no difference regarding
neck management. Regional progression (alone or with distant metastasis) was noted in 10 cases: 4 in
the neck observation group (4%) versus 6 in the neck dissection group (4%).
Conclusion: Elective lymph node dissection of irradiated neck should not be routinely performed in
patients undergoing surgery for persistent, recurrent or new primary pharyngo-laryngeal carcinomas
patients, those “salvage” procedures are associated with an
important per and postoperative complication rate, which can leadDespite the development and the improvement, the last de- to major quality of life alterations or even death [9e12]. It is thus
e treatment of pharyn- important, in those patients presenting with serious comorbiditiesgeal and laryngeal cancers, situations of recurrent or new primary
carcinomas are still frequent [1e3]. Those situations are associated
with a poor prognosis, as the 5-year overall survival rate decreases
to 20% [4e8].
Although surgery is today the best chance of cure for these
* Corresponding author. Department of Surgery, University Cancer Institute
Toulouse - Oncopôle, University Hospital of Toulouse, 1 Avenue Irene Joliot-Curie,z).and pre-existent sequels, to propose a comprehensive approach to
their overall burden, by weighing up their chance of cure and the
impact on quality of life in the therapeutic proposal [6,13,14].
Thereby, management of the N0 neck during surgery occurring
after primary RT is still controversial. Nowadays, few studies have
reported inhomogeneous results about the benefits of elective neck
dissection (ND) in terms of overall survival or loco-regional control
in those situations [15]. However, the morbidity associated with
this additional procedure is real, considering the negative impact
on healing (increased risk of salivary fistulae) and the higher rate of
postoperative complications and long term sequels [12,16,17].
The objective of our study is to compare the oncologic outcomes
of patients undergoing surgery for recurrent, persistent or new
primary N0 pharyngo-laryngeal cancer after loco-regional RT
regarding neck management.
Material and methods
Study design and patient selection
This multicentric retrospective study was based on all consec-
utive cases of oropharyngeal, hypopharyngeal or laryngeal surgery
for squamous cell carcinomas performed between 2005 and 2015
in two French tertiary referral centers (n ¼ 2988).
We included patients undergoing surgery for N0 persistent,
recurrent or new primary carcinoma in those locations following a
primary treatment including loco-regional RT. We included only
cases in which the lymphatic basin of the operated tumor was
previously irradiated, meaning that RT concerned at least levels II,
III, and IV on the Robbins classification [18]. Cases of prior ND were
excluded, as well as T1 carcinomas of the vocal cords considering
their poor potential for nodal spread.
Treatment
Initially, the RT protocol had to deliver at least a dose of 45 Gy
into the lateral neck compartment, on the side of the operated
carcinoma (or bilaterally if the tumor crossed the midline). The
surgery had to be performed in a curative attempt in patients with
no clinical or radiological evidence of lymph node involvement.
The ND were classified as “selective” when concerning levels II,
III and IV, “modified radical”when extended to level V (and/or level
I) and “supra-selective” when levels IIb or IV were omitted, as re-
ported in the AAO-HNS guideline statements. The central neck
compartment (level VI) was not considered in the ND analysis as it
owns specific indications and side effects.
A persistent disease was defined as the absence of total
macroscopic regression (clinical or radiological) of the tumor after
RT. A recurrence was defined as a histology proven SCC on the same
location after RT, with at least one examination demonstrating the
absence of macroscopic residual disease between the two di-
agnoses. Any case of tumor on another locationwas considered as a
new primary carcinoma. Regarding tumor resection, positive mar-
gins status was defined as excision limits under 1 mm or in contact
with the tumor after pathology. We chose a 3 mm margin cut-off
between close and clear margins, as it permits a better staging
between patients with intermediate or high risk of recurrence,
according to the local multidisciplinary boards.
The decision whether to perform an ND during surgery was
taken by a multidisciplinary board at each center, balancing the
expected risk of occult neck metastases with the estimated addi-
tional morbidity of the procedure. No standardization of the sur-
gery and the neck treatment decision can be assured upon by the
board, as there is no consensual referential regarding this situation.
Data analysis
The data collected included initial and metachronous cancer
characteristics, RT and surgery modalities including the type and
extent of neck irradiation and ND, postoperative complications and
long-term oncological outcomes. We collected as postoperative
complications: salivary fistulae, neck collection or abscess, cervical
hematoma, chyle leakage, necessary return to the operating room
and death. Paratracheal lymph nodemetastases were considered as
distant progression.
The main outcomes evaluated were overall survival (OS),progression-free survival (PFS) and cumulative incidence of nodal
progression between the patients who benefited from a neck
dissection (ND group) and those for whom the neck was observed
(NO group). The secondary outcomes evaluated were the occult
nodal involvement rate in patients who benefited from a ND.
Statistical analysis
Qualitative variables were summarized as frequencies and per-
centages for each category, and continuous variables as medians
and ranges. Comparisons between groups were assessed using Chi-
square or Fisher's exact test for qualitative variables and
KruskaleWallis test for continuous variables.
All survival times were calculated from the date of surgery.
Survival rates were estimated by the Kaplan Meier method using
the following first-event definitions: relapse (local, nodal or
distant) or death for PFS, and death for OS. Patients event free or
alive were censored at the time of their last follow-up. Univariable
analyses were performed using the log-rank test. Multivariable
analyses were assessed using the Cox proportional hazards model
which included clinically relevant factors.
Cumulative incidences of nodal progression (alone or associated
with distant metastasis) were estimated using a competing risk
methodology (Kalbfleish and Prentice method), which considered
other progressions and death as competing events. Comparisons of
cumulative incidences between groups were performed using
Gray's test in univariable analyses.
All reported p-values were two-sided. Differences were
considered significant at a 5% level.
Results
Patients and procedures [Table 1]
A total of 239 patients were included, represented by most
males (84%), with a median age of 61 at the time of surgery [Range:
25e88]. Ninety-five percent of them were tobacco smokers and
64% had excessive alcohol consumption.
The primary treatment with RT was performed for stage T1 or
T2 tumors in 50% of the cases. A nodal involvement was associated
with 87 cases (36%). Most of these procedures (68%) included a
concomitant biotherapy (platine-based chemotherapy or Cetux-
imab) and were performed with tridimensional conformational RT
(70%).
The salvage surgery was indicated for an oropharyngeal carci-
noma in 106 cases (44%), a laryngeal carcinoma in 81 cases (34%)
and a hypopharyngeal carcinoma in 52 cases (22%). The procedure
concerned a persistent, recurrent and new primary carcinoma in
respectively 19%, 47% and 34% of cases, with tumors staged T1 or T2
in 43% of cases (n ¼ 102) and T3 or T4 in 57% of cases (n ¼ 137).
An elective NDwas performed in 143 patients (60%), concerning
both sides in 45 cases. The ND (n¼ 188) were classified as modified
radical in 29 cases (15%), selective in 115 cases (61%) and supra-
selective in 44 cases (23%). Regarding the T-stage at surgery, we
noted 42% of T1 or T2 tumors and 58% of T3 or T4 tumors, with no
difference between the ND and NO groups (p ¼ 0,78). The pro-
cedure included a mucosal reconstruction in 56% cases in the ND
group, versus only 38% in the NO group (p ¼ 0.005).
Postoperative outcomes [Tables 2 and 3]
Regarding the pathology, the final margin status was considered
positive in 46 patients (19%). Among the others, the margins were
estimated clear in 125 patients (52%) and close in 68 patients (29%).
We noted no difference between the NO and ND groups regarding
Table 1
Patient characteristics (n ¼ 239).
Total (n ¼ 239) NO group (n ¼ 96) ND group (n ¼ 143) p value
Sex p ¼ 0.23
male 200 (84%) 77 (80%) 123 (86%)
female 39 (16%) 19 (20%) 20 (14%)
Age (at time of surgery) 61 [25e88] 63 [25e88] 60 [40e85] p ¼ 0.02
Use history
tabaco 214 (95%) 85 (94%) 129 (95%) p ¼ 1.00
alcohol 142 (64%) 52 (61%) 90 (67%) p ¼ 0.35
RADIOTHERAPY
Location p ¼ 0.54
oropharynx 90 (38%) 31 (32%) 59 (41%)
hypopharynx 51 (21%) 22 (23%) 29 (20%)
larynx 90 (38%) 39 (41%) 51 (36%)
other 8 (3%) 4 (4%) 4 (3%)
N stage p ¼ 0.03
N0 143 (62%) 50 (54%) 93 (68%)
Nþ 87 (36%) 43 (46%) 44 (32%)
NA 9 3 6
Type of radiotherapy p ¼ 0.39
exclusive 77 (32%) 34 (35%) 43 (30%)
concurrent chemotherapy 162 (68%) 62 (65%) 100 (70%)
Radiation modality p ¼ 0.47
IMRT 71 (30%) 26 (27%) 45 (31%)
3D CRT 168 (70%) 70 (73%) 98 (69%)
SURGERY
Location p ¼ 0.77
Oropharynx 106 (44%) 45 (47%) 61 (43%)
Hypopharynx 52 (22%) 19 (20%) 33 (23%)
Larynx 81 (34%) 32 (33%) 49 (34%)
Surgery context p ¼ 0.06
persistent carcinoma 46 (19%) 15 (16%) 31 (22%)
recurrent carcinoma 112 (47%) 40 (42%) 72 (50%)
new primary carcinoma 81 (34%) 41 (43%) 40 (28%)
T stage p ¼78
T1-T2 102 (43%) 42 (44%) 60 (42%)
T3-T4 137 (57%) 54 (56%) 83 (58%)
3D CRT: three-dimensional conformal radiation therapy.
IMRT: intensity modulated radiation therapy.the excision margins (23% of positive margins in the NO group
versus 17% in the ND group, p ¼ 0.44).
An adjuvant therapy was proposed for 53 patients: 15% of pa-
tients in the NO group versus 27% of patients in the ND group
(p ¼ 0.02) and consisted of RT in 27 cases, concurrent bio-RT in 22
cases, surgery re-excision in 2 cases and brachytherapy in 2 cases.Table 2
Postoperative outcomes.
Total (n ¼ 239) Neck o
Mucosal reconstruction 116 (49%) 36 (37
local flap 4 3
pedicled flap 65 26
free flap 47 7
Length of stay (days): median [Range] 21 [3e108] 19 [3e
Post-operative complications 92 (38%) 32 (33
salivary fistulae 78 30
neck collection 41 17
hematoma 9 2
chyle leakage 3 0
returning to operating room 44 15
death 9 3
Margin status
positive 46 (19%) 22 (23
close (<3 mm) 68 (29%) 24 (25
clear (>3 mm) 125 (52%) 50 (52
Adjuvant therapy 53 (22%) 14 (15
exclusive RT 27 8
concurrent bio-RT 22 3
surgery 2 1
brachytherapy 2 2The median hospital stay was 19 days in the NO group versus 22
days in the ND group (p¼ 0.004) with a postoperative complication
rate of 33% versus 42% respectively (p ¼ 0.18). The most important
complicationwas salivary fistulae, occurring in 33% of cases: 31% in
the NO group and 34% in the ND group (p¼ 0.71). We noted 9 cases
of postoperative death: 3 (3%) in the NO group versus 6 (4%) in thebservation (n ¼ 96) Neck dissection (n ¼ 143) p value
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Occult neck metastasis distribution in the ND group.
pN0 group (n ¼ 130) pN þ group (n ¼ 13) p value
RADIOTHERAPY
Type of radiotherapy p ¼ 0.75
Exclusive 31% 23%
Concurrent biotherapy 69% 77%
Radiation modality p ¼ 1.0
3D CRT 69% 69%
IMRT 31% 31%
T stage p ¼ 0.62
T1/T2 49% 42%
T3/T4 51% 58%
(unknown stage for 13 patients)
N stage p ¼ 0.05
N0 70% 42%
Nþ 30% 58%
(unknown stage for 9 patients)
SURGERY




Surgery context p ¼ 0.86
Persistent carcinoma 22% 15%
Recurrent carcinoma 50% 54%
New primary carcinoma 28% 31%
Radiologic assessment p ¼ 0.76
p ¼ 0.55MRI 30% 23%
PET 35% 46%
T stage p ¼ 0.74
T1/T2 42% 46%
T3/T4 58% 54%
3D CRT: three-dimensional conformal radiation therapy.
IMRT: intensity modulated radiation therapy.
MRI: magnetic resonance imaging.
PET: positron emission tomography.ND group (p ¼ 0.74). Four cases of death were linked to massive
hemorrhages secondary to salivary fistulae, 3 of which (75%)
benefited from an ND.
Occult nodal metastases were noted in 13 patients (9%) among
the entire ND group. It concerned a single node for 6 patients,
multiples nodes for 7 patients and an extra-capsular nodal spread
were noted in 7 patients (54%). Occult metastasis rate was esti-
mated at 6% for laryngeal carcinomas, 7% for oropharyngeal carci-
nomas and 18% for hypopharyngeal carcinomas (p ¼ 0.16). It
concerned level IIa and III in most cases, as level IIb and IV were
involved in only 2 cases (out of 172 and 148 dissected levels
respectively).
In our exploratory analysis, occult nodal metastases affected
more likely patients with positive N stage at the time of RT, as it
reached 16% for these patients.
Otherwise, tumor sub-location, T stage (initial and at surgery),
context of surgery (persistent, recurrent or new primary carci-
noma), RT modalities and delay between radiotherapy and surgery
were not associated with presence of occult nodal metastasis.Oncologic outcomes [Figs. 1 and 2]
With amedian follow-up of 60months after surgery, we noted a
relapse of the carcinoma in 115 cases (48%). It consisted of local
progression in most of the cases (n¼ 86, 75%), including 14 cases of
new primary carcinoma. We observed 26 cases of nodal progres-
sion (12 in the NO group versus 14 in the ND group), 16 of which
(62%) were associated with a new local progression, while isolated
nodal progression occurred in 10 cases: 4 in the NO group versus 6
in the ND group.
Among the 75 patients who presented a progression withoutdistant metastasis (local and/or nodal), only 27% were able to
benefit from salvage procedure (by surgery or RT).
The median overall survival (OS) and median progression-free
survival (PFS) were estimated at 34 months (95%IC [27e48]) and
25 months (95%IC [16e34]) respectively. We noted no difference
between the NO and ND groups regarding the OS and PFS in uni-
variable andmultivariable analysis (OS HR 0.91 [0.65e1.28] and PFS
HR 0.91 [0.65e1.27] for the ND group inmultivariable analysis). Age
at surgery (patients under 60), delay between RTand surgery over 2
years and laryngeal carcinomas were associated with better OS
(p ¼ 0.002, p ¼ 0.03 and p ¼ 0.05 respectively) and PFS (p ¼ 0.01,
p ¼ 0.08 and p ¼ 0.09), and positive excision margins were asso-
ciated with worst outcomes (p < 0.0001 in OS and PFS) [Table 4].
Patients with laryngeal carcinomas had the best survival out-
comes with respectively median OS and PFS of 67 months (95%IC
[30e97]) and 51 months (95IC [25e90]), versus 33 (95%IC [21e48])
and 21 months (95%IC [13e35]) for oropharyngeal carcinomas and
27 (95%IC [18e38]) and 16 months (95%IC [13e33]) for hypophar-
yngeal carcinomas. In the separate analysis of the different loca-
tions, we noted no difference in OS and PFS between the NO and the
ND groups.
Regarding the regional control rate, we noted a 3.4% cumulative
incidence of nodal progression at 2 years [1.6e6.3] versus a 45.8%
cumulative incidence of other event [39e52], with no difference
between the NO and ND groups.Discussion
Since the first reports of Burge and Jonsson using lymphangi-
ography to assess lymphatic changes after irradiation, it has been
well established that over 40 Gy, the lymphatic vessels and nodes
Fig. 1. Relapse distribution.become hyalinized and fibrosed [19,20]. In their time, the authors
were the first to raise the possibility that these changes may serve
as a barrier for lymphatic dissemination of locally recurrent tumors
after previous irradiation. However, the standard of care for neck
management in case of salvage surgery after RT is still not estab-
lished, with no consensual guidelines nowadays [21,22].
In the literature, most of the published series concern salvage
total laryngectomy, with a wide range of occult nodal metastasis
rates, from 0 to 30% according to a recent review by Silverman, in
which most of the series didn't differentiate central and lateral ND
(while those procedures have different issues in our opinion) or
didn't report irradiation data (probably including cases of limited
glottic irradiation with no nodal prophylaxis) [23,24]. When the
salvage procedurewas extending to all head and neck locations, the
occult metastasis rate ranged from 3% to 12% in recurrent carci-
nomas presenting with N0 neck at both initial and recurrence and
up to 22% in initially positive necks according to Prendes in a case
series of 16 patients [15,25].
In our series, we report a low overall rate of occult nodal
metastasis, with no association with the T stage at surgery. Still, we
identified two high-risk situations regarding their occult nodal
metastasis potential: initial nodal involvement at the time of RTandhypopharyngeal carcinomas, although whether or not an ND was
performed in those situations did not affect survival outcomes.
Thus, it appears the occult nodal metastasis rate may not be an
efficient indicator for neck management. Besides, we observe in the
literature inhomogeneous results among retrospective series,
which explains why the cut-off value remains controversial since
the first decision-analysis model published in 1994 byWeiss, which
concluded that elective NDs should be performed for patients with
a suspected occult nodal metastasis rate higher than 20%. For
example, some have proposed different values, by arguing that the
data Weiss used in their algorithm have evolved, such as the better
initial nodal staging and the higher salvage rate in case of recur-
rence [26,27]. Hilly published recently their own decision-analysis
model for salvage laryngectomy, according to which routine elec-
tive ND was not recommended [28]. In our opinion, relying on
survival outcomes could be a more relevant indicator than the
occult metastasis rate, which has different significations and clin-
ical issues in salvage surgery than in upfront surgery.
Although retrospective, our series report no benefit of elective
ND in survival rates, without significant difference between the NO
and ND groups. In fact, the prognostic of these patients is likely to
be linked to the local control, as we report an important rate of local
Fig. 2. Overall survival, progression-free survival and cumulative incidence of nodal
progression (alone or associated with distant metastasis) curves.
Table 4




T stage at surgery
T1/T2 1 - 1 -
T3/T4 1.05 p ¼ 0.78 1,16 p ¼ 0.42
N stage before radiotherapy
N0 1 - 1 -
Nþ 1.03 p ¼ 0.87 1.00 p ¼ 0.98
Context of surgery
persistent carcinoma 1 - 1 -
recurrent carcinoma 0.96 p ¼ 0.87 0.83 p ¼ 0.43
new primary carcinoma 0.86 p ¼ 0.61 0.85 p ¼ 0.59
Limits of excision
R0 (close or clear margins) 1 - 1 -
R1 (positive margins) 3.48 p < 0.0001 3.39 p < 0.0001
Location
oropharynx 0.72 p ¼ 0.13 0.84 p ¼ 0.41
hypopharynx 1 - 1 -
larynx 0.61 p ¼ 0.05 0.66 p ¼ 0.09
Neck dissection
no 1 - 1 -
yes 0.92 p ¼ 0.64 0.92 p ¼ 0.61
Age at surgery
< 60 years 1 - 1 -
>60 years 1.72 p ¼ 0.002 1.57 p ¼ 0.01
Delay between RT and surgery
<2 years 1 - 1 -
>2 years 0.63 p ¼ 0.03 0.69 p ¼ 0,08tumor progression (36%) in our series with a very low salvage rate
in those new progressions. In fact, this rate seems closely linked to
the important insufficient or limited margin resection rate (of 48%
in our series), which illustrates the difficulty of those salvage pro-
cedures, and so the necessity to focus on the tumor resection
quality, with clinical excision margins over 1 or 2 cm during
surgery.Moreover, the absence of benefit of ND is highlighted by the fact
that among the 10 patients who developed a nodal progression
(alone or with distant metastasis), most belonged to the ND group
(n ¼ 6). Those results are particularly surprising given that the ND
group seems to have been treated more aggressively, with a lower
rate of insufficient margin resections at pathology (17 versus 23%
for the NO group, p ¼ 0,24) and with more adjuvant treatments
after surgery (28 versus 15%, p ¼ 0,02).
Concerning the additional morbidity of neck dissection, its
impact is nowwell documented, with long term sequels dominated
by cervical and shoulder dysfunction [16,29e31]. In a RTOG pro-
spective trial evaluating late toxicity after chemoradiation for
advanced head and neck carcinoma, secondary neck dissectionwas
significantly associated with moderate and severe late toxicity
(chronic laryngeal or pharyngeal toxicity grade > 3, organ
dysfunction or death) in multivariable analysis [32]. When coupled
to the tumor resection, it appeared that ND was associated with a
higher rate of postoperative complication rate in salvage laryn-
gectomy or pharyngo-laryngectomy, which were dominated by
salivary fistulae, according to two recent meta-analyses [33,34].
In our series, we report a complication rate similar to the liter-
ature, dominated by salivary fistula, without significant differences
between the NO and ND groups. However, we did not quantify the
importance of the fistula, which can be directly associated with the
morbi-mortality in the postoperative period, as we reported 3 cases
of death secondary to carotid blowout in the ND group, versus 1 in
the NO group. We noted a significant longer hospital stay in the ND
group, but we reported also more mucosal reconstructions in the
ND group. The similar postoperative outcomes may be partly
explained by the limited extent of ND when performed, with se-
lective or supra-selective ND in more than 80% cases, as the
complication rate seems to be directly linked to the extent of the
dissection, according to Van Den Bovenkamp [17].
Nowadays, with the recent advent of transoral robotic surgery
(TORS) demonstrating the functional benefits of avoiding cervico-
transoral communication in pharyngo-laryngeal procedures,
indications have developed and TORS is now well described for
salvage procedures [35]. In our opinion, those minimal invasive
procedures would particularly benefit from keeping their neck
unexplored in term of functional outcomes. In contrast, when a free
flap is necessary, an access to the neck is needed for anastomosis
and the dissection of the vascular axis may justify a neck explora-
tion, which should be as selective as possible. Indeed, occult nodal
metastasis were noted outside level IIa or III in only three cases in
our series, thereby raising the possibility of performing supra-
selective ND, which could lead to better functional outcomes,
notably on shoulder dysfunction by omitting level IIb.
Conclusion
Elective neck dissection should not be routinely performed in
patients undergoing surgery for persistent, recurrent or new pri-
mary N0 pharyngo-laryngeal carcinoma after radiotherapy
considering the low rate of occult nodal metastasis and the lack of
survival benefit.
In our opinion, elective lymph node dissection in irradiated neck
can be weighed up for high-risk tumors (hypopharyngeal carci-
nomas or persistent carcinomas with initial nodal involvement) or
when a free flap is considered, but it can be limited to level IIa and
III.
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